The objective of this randomized, double-blind, placebo-controlled, parallel-design clinical trial is to investigate the potential antioxidant benefits of a cranberry beverage. The investigators hypothesize the chronic consumption of this beverage will improve indices of oxidative stress, inflammation, endothelial function, and glucoregulation. The investigators also hypothesize that these benefits will be particularly evident following an oral glucose tolerance test.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Enrollment
79
beverage containing cranberry at a dose of 15.2 ounces per day for 56 days.
Placebo Comparator - beverage absent cranberry at a dose of 15.2 ounces per day for 56 days.
Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University
Boston, Massachusetts, United States
Washington State University
Pullman, Washington, United States
Change in biomarkers of inflammation compared with placebo
Time frame: Baseline and 8 weeks
Change in biomarkers of oxidative stress compared with placebo.
Time frame: Baseline and 8 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.